Cancer Institute A national cancer institute
designated cancer center

Phase II and Phase III Clinical Trials

Working across boundaries between the laboratory and clinic, program members are committed to bringing the latest medical breakthroughs to patients through a range of innovative Phase II and Phase III clinical trials. Approaches under study include monoclonal antibodies and genetically engineered vaccines developed from a patient's own cancer cells.

To see a list of active clinical trials, please visit the Find a Clinical Trial page.

Richard Hoppe, MD

Saul Rosenberg, MD


Stanford Medicine Resources:

Footer Links: